Neurological Intensive Care Unit, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada; Faculty of Medicine, Health Sciences Center, Kuwait University, Kuwait, Kuwait.
Infection Prevention and Control Department, Montreal Neurological Institute and Hospital, McGill University Health Center, Montreal, Quebec, Canada.
Am J Infect Control. 2018 Jun;46(6):656-662. doi: 10.1016/j.ajic.2017.12.001. Epub 2018 Feb 1.
Healthcare-associated infections (HAIs) occur frequently in neurological intensive care units (neuro-ICUs); however, data differentiating associations with various diagnostic categories and resulting burdens are limited. This prospective cohort study reported incidence rates, pathogen distribution, and patient-related outcomes of HAIs in a neuro-ICU population from April 2010 to March 2016.
Laboratory results and specific clinical indicators were used to categorize infections as per National Healthcare Safety Network nosocomial infection surveillance definitions. Patient outcomes studied included length of stay and mortality.
There were 6,033 neuro-ICU admissions resulting in 20,800 neuro-ICU days over the 6-year study period. A total of 227 HAIs were identified for a rate of 10.9/1,000 ICU days. Device-associated infections accounted for 80.6% of HAIs, with incidence rates (per 1,000 device days) being 18.4 for ventilator-associated pneumonia; 4.9 for catheter-associated urinary tract infections (CAUTIs); 4.0 for ventriculostomy-associated infections; and 0.6 for central line-associated blood stream infections (CLABSIs). Of the various diagnostic categories, subdural hematoma and intracerebral/intraventricular hemorrhage were associated with the highest pooled HAIs, with incidence rates of 21.3 and 21.1 per 1,000 neuro-ICU days, respectively. Prolonged neuro-ICU length of stay was strongly associated with all HAIs.
This large-scale surveillance study provides estimates of the risk of common HAIs in neurocritical care patients and their effect on hospitalization. Preventive strategies kept rates of infection very low, in particular CAUTI, CLABSI, and Clostridium difficile infections, and inhibited the emergence of resistant organisms.
医疗保健相关感染(HAI)在神经重症监护病房(神经 ICU)中经常发生;然而,区分各种诊断类别之间关联以及感染后果的数据有限。本前瞻性队列研究报告了 2010 年 4 月至 2016 年 3 月期间神经 ICU 人群中 HAI 的发病率、病原体分布和与患者相关的结局。
根据国家医疗保健安全网络医院感染监测定义,使用实验室结果和特定临床指标对感染进行分类。研究的患者结局包括住院时间和死亡率。
在 6 年的研究期间,共有 6033 例神经 ICU 入院,导致 20800 例神经 ICU 天。共发现 227 例 HAI,发病率为 10.9/1000 ICU 天。器械相关感染占 HAI 的 80.6%,发病率(每 1000 器械天)分别为:呼吸机相关性肺炎 18.4 例;导管相关尿路感染(CAUTI)4.9 例;脑室引流相关感染 4.0 例;中心静脉导管相关血流感染(CLABSI)0.6 例。在各种诊断类别中,硬膜下血肿和脑内/脑室内出血与 HAI 的相关性最高,发病率分别为 21.3 和 21.1/1000 神经 ICU 天。神经 ICU 住院时间延长与所有 HAI 密切相关。
这项大规模监测研究提供了神经危重病患者常见 HAI 风险及其对住院时间的影响的估计。预防策略使感染率非常低,特别是 CAUTI、CLABSI 和艰难梭菌感染,并且抑制了耐药菌的出现。